Clinical Trials Finder

Independent ClinicalTrials.gov directory

Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 5:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 971 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Healthy Adult Volunteers Clear all

Completed Phase 1 Interventional

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

NCT00321061

View directory record Official record

Conditions: HIV Infections
Interventions: VRC-HIVDNA016-00, VRC-HIVADV014-00; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years

Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Source: ClinicalTrials.gov public record

Updated Jul 1, 2017 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 3 Interventional Accepts healthy volunteers

A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults

NCT00301639

View directory record Official record

Conditions: Healthy Volunteers
Interventions: OROS methylphenidate hydrochloride, methylphenidate hydrochloride; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years

Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Source: ClinicalTrials.gov public record

Updated Jul 11, 2011 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects

NCT01140672

View directory record Official record

Conditions: Healthy
Interventions: PF-04634817; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: New Haven, Connecticut

Source: ClinicalTrials.gov public record

Updated Jun 7, 2011 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional

A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

NCT05797753

View directory record Official record

Conditions: Amyotrophic Lateral Sclerosis, Healthy Volunteer
Interventions: SAR443820, Erythromycin ethyl succinate, Itraconazole; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Source: ClinicalTrials.gov public record

Updated Jan 2, 2025 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

Drug-Drug Interaction Study in Health Adult Volunteers

NCT02273986

View directory record Official record

Conditions: Healthy
Interventions: Digoxin, K-877; Drug
Lead sponsor: Kowa Research Institute, Inc.; Industry
Eligibility: 18 Years to 45 Years

Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2014
U.S. locations: 1
States / cities: Austin, Texas

Source: ClinicalTrials.gov public record

Updated Oct 23, 2014 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

NCT01660477

View directory record Official record

Conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Lopinavir/Ritonavir, Healthy Volunteers
Interventions: Isavuconazole, Lopinavir/ritonavir; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Glendale, California

Source: ClinicalTrials.gov public record

Updated Feb 22, 2015 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects

NCT03202927

View directory record Official record

Conditions: Healthy Volunteers
Interventions: PEGFILGRASTIM; Drug
Lead sponsor: Adello Biologics, LLC; Industry
Eligibility: 19 Years to 55 Years

Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Tempe, Arizona • Lincoln, Nebraska

Source: ClinicalTrials.gov public record

Updated Jul 4, 2018 · Synced May 22, 2026, 5:47 AM EDT

Completed No phase listed Observational Accepts healthy volunteers

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

NCT00899795

View directory record Official record

Conditions: Leukemia, Myelodysplastic Syndromes
Interventions: cytogenetic analysis, fluorescence in situ hybridization, flow cytometry, biopsy; Genetic · Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 5 Years to 120 Years

Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Source: ClinicalTrials.gov public record

Updated Dec 3, 2017 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 2 Interventional Accepts healthy volunteers

Challenge Study of an ETEC Vaccine

NCT01922856

View directory record Official record

Conditions: Enteritis; Escherichia Coli, Enterotoxigenic
Interventions: LTR192G with dscCfaE, No Intervention; Biological · Other
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 50 Years

Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Baltimore, Maryland • Silver Spring, Maryland

Source: ClinicalTrials.gov public record

Updated Jul 5, 2017 · Synced May 22, 2026, 5:47 AM EDT

Completed Not applicable Interventional Accepts healthy volunteers

Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay

NCT00508950

View directory record Official record

Conditions: Healthy
Interventions: Large volume blood draw; Procedure
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years

Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2016
U.S. locations: 1
States / cities: Secaucus, New Jersey

Source: ClinicalTrials.gov public record

Updated Aug 16, 2016 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers Results available

Drug-Drug Interaction Study of Colchicine and Theophylline

NCT00983905

View directory record Official record

Conditions: Pharmacokinetics
Interventions: Theophylline, Colchicine; Drug
Lead sponsor: Mutual Pharmaceutical Company, Inc.; Industry
Eligibility: 18 Years to 45 Years

Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Fargo, North Dakota

Source: ClinicalTrials.gov public record

Updated Mar 1, 2010 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers Results available

Safety Study of Efprezimod Alfa (CD24Fc, MK-7110) When Administered Intravenously in Healthy Adult Subjects (MK-7110-001)

NCT02650895

View directory record Official record

Conditions: Healthy Volunteers
Interventions: Efprezimod alfa, Saline; Biological · Drug
Lead sponsor: Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years to 55 Years

Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Source: ClinicalTrials.gov public record

Updated Jan 11, 2023 · Synced May 22, 2026, 5:47 AM EDT

Recruiting Not applicable Interventional Accepts healthy volunteers

Visual Arts Interventions With Older Adults

NCT06645652

View directory record Official record

Conditions: Feasibility Study
Interventions: Training in observational drawing, Arts engagement through digital galleries; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 55 Years to 85 Years

Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Source: ClinicalTrials.gov public record

Updated Apr 19, 2026 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole

NCT04139226

View directory record Official record

Conditions: Healthy Volunteers
Interventions: CC-11050; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Antonio, Texas

Source: ClinicalTrials.gov public record

Updated Jun 21, 2020 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect

NCT04077879

View directory record Official record

Conditions: Healthy Volunteers
Interventions: ASP1617, Placebo; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Glendale, California

Source: ClinicalTrials.gov public record

Updated Oct 22, 2024 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)

NCT04772885

View directory record Official record

Conditions: Healthy Volunteer, Atopic Dermatitis, Hidradenitis Suppurativa
Interventions: KT-474/Placebo, KT-474; Drug
Lead sponsor: Kymera Therapeutics, Inc.; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 154 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 14
States / cities: Phoenix, Arizona • Sun City West, Arizona • Boynton Beach, Florida + 8 more

Source: ClinicalTrials.gov public record

Updated Oct 23, 2022 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers

NCT01531647

View directory record Official record

Conditions: Healthy Volunteer
Interventions: danoprevir, raltegravir, ritonavir; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Lenexa, Kansas

Source: ClinicalTrials.gov public record

Updated Nov 1, 2016 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.

NCT03137134

View directory record Official record

Conditions: Healthy
Interventions: Crizotinib, Esomeprazole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Source: ClinicalTrials.gov public record

Updated Oct 30, 2017 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Study of TAK-279 in Adults With or Without Liver Damage

NCT05976321

View directory record Official record

Conditions: Hepatic Impairment, Healthy Volunteers
Interventions: TAK-279; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older

Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Miami, Florida • Orlando, Florida • San Antonio, Texas

Source: ClinicalTrials.gov public record

Updated Aug 28, 2024 · Synced May 22, 2026, 5:47 AM EDT

Terminated Phase 1 Interventional

Nitrous Oxide Vasodilation Healthy Adult Volunteers

NCT01785030

View directory record Official record

Conditions: Peripheral Vein Vasodilation
Interventions: 50% Nitrous oxide; Drug
Lead sponsor: Columbia University; Other
Eligibility: 19 Years and older

Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New York, New York

Source: ClinicalTrials.gov public record

Updated Jan 15, 2019 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers Results available

A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects

NCT02415439

View directory record Official record

Conditions: Healthy
Interventions: VBP15, Placebo; Drug
Lead sponsor: ReveraGen BioPharma, Inc.; Industry
Eligibility: 18 Years to 65 Years

Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lenexa, Kansas

Source: ClinicalTrials.gov public record

Updated Mar 9, 2017 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers

NCT04092712

View directory record Official record

Conditions: Healthy Volunteers
Interventions: [14C]-CTP-543; Drug
Lead sponsor: Concert Pharmaceuticals; Industry
Eligibility: 19 Years to 55 Years · Male only

Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Lincoln, Nebraska

Source: ClinicalTrials.gov public record

Updated Sep 24, 2019 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants

NCT05796479

View directory record Official record

Conditions: Healthy Volunteers
Interventions: Amlitelimab DP1, Amlitelimab DP2; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Hialeah, Florida

Source: ClinicalTrials.gov public record

Updated Sep 18, 2025 · Synced May 22, 2026, 5:47 AM EDT

Completed Phase 1 Interventional Accepts healthy volunteers

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects

NCT01711827

View directory record Official record

Conditions: Healthy Subjects, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Prednisolone
Interventions: Isavuconazole, Prednisone; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years to 55 Years

Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Glendale, California

Source: ClinicalTrials.gov public record

Updated Oct 21, 2012 · Synced May 22, 2026, 5:47 AM EDT